The prevalence of nonalcoholic fatty liver disease (NAFLD) is rising. NAFLD/nonalcoholic
steatohepatitis (NASH) is associated not only with hepatic morbidity and mortality but also …

One of the newly recognized types of cell death is ferroptosis which is related to the
accumulation of iron and lipid-reactive oxygen species. Ferroptosis is considered a …

Nonalcoholic fatty liver disease (NAFLD) is a worldwide rising challenge because of hepatic,
but also extrahepatic, complications. Thyroid hormones are master regulators of energy and …

The obesity pandemic is accompanied by increased risk of developing metabolic syndrome
(MetS) and related conditions: non-alcoholic fatty liver disease (NAFLD)/non-alcoholic …

Steatotic liver disease (SLD) displays a dynamic and complex disease phenotype.
Consequently, the metabolic dysfunction-associated steatotic liver disease …

Nonalcoholic fatty liver disease (NAFLD), sarcopenia and sarcopenic obesity (SO) are
highly prevalent conditions that may coexist, especially in the aging population, without any …

Non-alcoholic fatty liver disease (NAFLD) is a definition of a prevalent condition that has
been given a name describing what the disease is not, mainly due to gaps in the …

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease, and is
related to fatal and non-fatal liver, metabolic, and cardiovascular complications. Its non …

The term non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common
type of chronic liver disease. NAFLD points to excessive hepatic fat storage and no evidence …

Nonalcoholic steatohepatitis (NASH) is epidemiologically associated with obesity and
diabetes and can lead to liver cirrhosis and hepatocellular carcinoma if left untreated. The …